The cannabis-attributable driving harms and costs are substantial. The harm and cost of cannabis-related collisions is an important factor to consider as Canada looks to legalize and regulate the sale of cannabis. This analysis provides evidence to help inform Canadian policy to reduce the human and economic costs of drug-impaired driving.
As Canada's elderly continue to represent the fastest growing population in Canada, there has been an increasing need for effective and efficient screening tools for senior drivers, especially ones which identify possible cognitive impairments. Thus, the objective of this study was to conduct a meta-analysis of the available research surrounding the predictive value of pencil-and-paper cognitive screening tools. A systematic review of existing literature was conducted, with a final sample of 15 evaluation outcomes that identified 10 different pencil-and-paper tools. Multiple techniques were used to evaluate the data, including random effects modeling, meta-regression analysis and tests for bias, including publication bias. Finally, a multilevel meta-regression model was used to account for dependence of evaluation outcomes coming from the same study. A small to medium-sized significant pooled effect of 1.94 was found, indicating that when pencil-and-paper cognitive screening tools predict a driver is unsafe, there is a 94% greater chance that this driver will exhibit unsafe driving behaviors. Results, however, only provide partial evidence to inform the selection of pencil-and-paper cognitive screening tools, as it was not possible to unequivocally identify which tool performed best.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.